Search Investor Relations

Corporate Governance

 

Board of Directors

Omid Farokhzad image

Omid Farokhzad

Chair & Chief Executive Officer
Meeta  Gulyani image

Meeta Gulyani

Head of Strategy, Business Development and Transformation at Millipore Sigma
David Hallal image

David Hallal

Former Chief Executive Officer at Alexion Pharmaceuticals
Robert Langer, Sc.D. image

Robert Langer, Sc.D.

Co-Chairman of Scientific Advisory Board
Terry McGuire image

Terry McGuire

Founding Partner of Polaris Partners
Deep  Nishar image

Deep Nishar

Partner at General Catalyst
 

Committee Composition

Director Name Audit Committee Corporate Governance and Nominating Committee Science and Technology Committee Talent and Compensation Committee
Meeta Gulyani Chairperson of the Audit Committee
David Hallal Independent Director Chairperson of the Corporate Governance and Nominating Committee Member of the Talent and Compensation Committee
Robert Langer, Sc.D. Chairperson of the Science and Technology Committee
Terry McGuire Member of the Audit Committee Chairperson of the Talent and Compensation Committee
Deep Nishar Member of the Corporate Governance and Nominating Committee Member of the Science and Technology Committee
Legend = Independent Director = Chairperson = Member
  • Independent Director
  • Chairperson
  • Member
 

Clinical & Scientific Advisors

Robert Langer, Sc.D. image

Robert Langer, Sc.D.

Co-Chairman of Scientific Advisory Board
Steven Carr, Ph.D. image

Steven Carr, Ph.D.

Senior Director of Proteomics at the Broad Institute of MIT and Harvard
Vivek Farias, Ph.D. image

Vivek Farias, Ph.D.

Chair of Data Committee
Charles Cantor, Ph.D. image

Charles Cantor, Ph.D.

Emeritus Professor at Boston University
Jennifer  Van Eyk, Ph.D. image

Jennifer Van Eyk, Ph.D.

Erika Glazer Chair in Women's Heart Health, Director of Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences, Director of Basic Science Research in the Women's Heart Center, Professor in Medicine and in Biomedical Sciences at Ce
Josh  Coon, Ph.D. image

Josh Coon, Ph.D.

Chair of Proteomics Committee
Luis Diaz, M.D. image

Luis Diaz, M.D.

Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering
Chris Mason, Ph.D. image

Chris Mason, Ph.D.

Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine; Director of the WorldQuant Initiative for Quantitative Prediction
Mark McClellan, Ph.D., M.D. image

Mark McClellan, Ph.D., M.D.

Founding Director of the Duke-Margolis Center for Health Policy
Bruce Wilcox, Ph.D. image

Bruce Wilcox, Ph.D.

Chief Technology Officer at PrognomiQ
 

Governance

The Board of Directors of Seer, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.